Melflufen Study: Lengthy Time To Next Treatment, Signific...

Melflufen Study: Lengthy Time To Next Treatment, Significant Reduction In Bone Pain, Positive Feedback From FDA Regarding HORIZON Study
Annual Meeting Photo

Annual Meeting
3 ปี 559 Views
ประเภท:
ลักษณะ:
Jakob Lindberg CEO Of Oncopeptides Discusses Melflufen Study: Lengthy Time To Next Treatment, Significant Reduction In Bone Pain, Positive Feedback From FDA Regarding HORIZON Study